Pharmacokinetics and dose individualization of ceftriaxone in a hepatically-impaired, critically-ill patient receiving continuous venovenous hemofiltration

Int J Clin Pharmacol Ther. 2018 Mar;56(3):148-150. doi: 10.5414/CP203149.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacokinetics
  • Ceftriaxone / administration & dosage*
  • Ceftriaxone / pharmacokinetics
  • Critical Illness
  • Dose-Response Relationship, Drug
  • Hemofiltration*
  • Humans
  • Liver Failure / complications*
  • Male
  • Renal Insufficiency / therapy

Substances

  • Anti-Bacterial Agents
  • Ceftriaxone